CD137, an attractive candidate for the immunotherapy of lung cancer-Reference-Cited by-同舟云学术

CD137, an attractive candidate for the immunotherapy of lung cancer

Published:2020-04-03 Issue:5 Volume:111 Page:1461-1467
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Ye Lingyun¹²,Jia Keyi¹²,Wang Lei¹,Li Wei¹,Chen Bin¹,Liu Yu¹²,Wang Hao¹²,Zhao Sha¹,He Yayi¹^ORCID,Zhou Caicun¹

Affiliation:

1. Department of Medical Oncology Shanghai Pulmonary Hospital Tongji University Medical School Cancer Institute Tongji University School of Medicine Shanghai China

2. Medical school Tongji University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14354

Reference64 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. LAG-3 Protein Expression in Non–Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes

3. KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer

4. 4-1BB (CD137), an inducible costimulatory receptor, as a specific target for cancer therapy

5. An Update on Anti-CD137 Antibodies in Immunotherapies for Cancer

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD137 expression and signal function drive pleiotropic γδ T-cell effector functions that inhibit intracellular M. tuberculosis growth;Clinical Immunology;2024-09

2. The reactive stroma response regulates the immune landscape in prostate cancer;Journal of Translational Genetics and Genomics;2024-07-24

3. Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors;Journal for ImmunoTherapy of Cancer;2024-03

4. Prognostic Significance of the Microenvironment in Human Papillomavirus Oropharyngeal Carcinoma: A Systematic Review;The Laryngoscope;2023-08-29

5. MiR-654-3p, reduced by the excessive ALKBH5, Alleviated the Inflammation in OA by targeting TNFRSF9, the trigger of the NF-κB pathway;Biochemical and Biophysical Research Communications;2022-12